» Articles » PMID: 29352721

Hyperconnective and Hypoconnective Cortical and Subcortical Functional Networks in Multiple System Atrophy

Overview
Specialty Neurology
Date 2018 Jan 21
PMID 29352721
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In multiple system atrophy (MSA), the organization of the functional brain connectivity within cortical and subcortical networks and its clinical correlates remains to be investigated.

Methods: Whole-brain based 'resting-state' fMRI data were obtained from 22 MSA patients (11 MSA-C, 11 MSA-P) and 22 matched healthy controls, together with standardized clinical assessment and video-oculographic recordings (EyeLink).

Results: MSA patients vs. controls showed significantly higher ponto-cerebellar functional connectivity and lower default mode network connectivity (p < .05, corrected). No differences were observed in the motor network and in the control network. The higher the ponto-cerebellar network functional connectivity was, the more pronounced was smooth pursuit impairment.

Conclusion: This functional connectivity analysis supports a network-dependent combination of hyper- and hypoconnectivity states in MSA, in agreement with adaptive compensatory responses (hyperconnectivity) and a function disconnection syndrome (hypoconnectivity) that may occur in a consecutive sequence.

Citing Articles

Progressive gray matter atrophy in parkinsonian variant of multiple system atrophy assessed by using causal structural covariance network.

Wu T, Zhang Y, Xia K, Hu S, Wang S Neuroradiology. 2024; 66(11):1931-1939.

PMID: 39222076 DOI: 10.1007/s00234-024-03456-2.


Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia.

Piramide N, De Micco R, Siciliano M, Silvestro M, Tessitore A Curr Neurol Neurosci Rep. 2024; 24(10):461-477.

PMID: 39046642 PMC: 11415422. DOI: 10.1007/s11910-024-01365-8.


Stepwise Functional Brain Architecture Correlates with Atrophy in Progressive Supranuclear Palsy.

Spinelli E, Ghirelli A, Bottale I, Basaia S, Canu E, Castelnovo V Mov Disord. 2024; 39(9):1493-1503.

PMID: 38881298 PMC: 11499047. DOI: 10.1002/mds.29887.


Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?.

Savoie F, Arpin D, Vaillancourt D Curr Neuropharmacol. 2023; 22(10):1583-1605.

PMID: 37533246 PMC: 11284713. DOI: 10.2174/1570159X21666230801140648.


Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study.

Cuoco S, Ponticorvo S, Bisogno R, Manara R, Esposito F, Di Salle G Cerebellum. 2022; 22(5):810-817.

PMID: 35982370 PMC: 10485110. DOI: 10.1007/s12311-022-01455-8.